Literature DB >> 17047104

An unfavourable prognosis for pancreatic cancer indicates fields of opportunity.

W Greenhalf1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17047104      PMCID： PMC1860079          DOI： 10.1136/gut.2006.098814

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  13 in total

1.  Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.

Authors:  David A Tuveson; Alice T Shaw; Nicholas A Willis; Daniel P Silver; Erica L Jackson; Sandy Chang; Kim L Mercer; Rebecca Grochow; Hanno Hock; Denise Crowley; Sunil R Hingorani; Tal Zaks; Catrina King; Michael A Jacobetz; Lifu Wang; Roderick T Bronson; Stuart H Orkin; Ronald A DePinho; Tyler Jacks
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

2.  Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement.

Authors:  Dean Bogoevski; Emre F Yekebas; Paulus Schurr; Jussuf T Kaifi; Asad Kutup; Andreas Erbersdobler; Klaus Pantel; Jakob R Izbicki
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

3.  Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.

Authors:  J Kim; H A Reber; S M Dry; D Elashoff; S L Chen; N Umetani; M Kitago; O J Hines; K K Kazanjian; S Hiramatsu; A J Bilchik; S Yong; M Shoup; D S B Hoon
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

4.  Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

Authors:  J P Neoptolemos; D D Stocken; J A Dunn; J Almond; H G Beger; P Pederzoli; C Bassi; C Dervenis; L Fernandez-Cruz; F Lacaine; J Buckels; M Deakin; F A Adab; R Sutton; C Imrie; I Ihse; T Tihanyi; A Olah; S Pedrazzoli; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

Review 5.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

6.  Results of total pancreatectomy for adenocarcinoma of the pancreas.

Authors:  H M Karpoff; D S Klimstra; M F Brennan; K C Conlon
Journal:  Arch Surg       Date:  2001-01

7.  Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure.

Authors:  A C Paulino
Journal:  Am J Clin Oncol       Date:  1999-10       Impact factor: 2.339

8.  Allelotype of pancreatic adenocarcinoma.

Authors:  A B Seymour; R H Hruban; M Redston; C Caldas; S M Powell; K W Kinzler; C J Yeo; S E Kern
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

9.  Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.

Authors:  J A Brennan; L Mao; R H Hruban; J O Boyle; Y J Eby; W M Koch; S N Goodman; D Sidransky
Journal:  N Engl J Med       Date:  1995-02-16       Impact factor: 91.245

10.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Authors:  John P Neoptolemos; Deborah D Stocken; Helmut Friess; Claudio Bassi; Janet A Dunn; Helen Hickey; Hans Beger; Laureano Fernandez-Cruz; Christos Dervenis; François Lacaine; Massimo Falconi; Paolo Pederzoli; Akos Pap; David Spooner; David J Kerr; Markus W Büchler
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245
View more
  1 in total

1.  Risk of additional pancreatic cancer in patients with branch duct intraductal papillary-mucinous neoplasm.

Authors:  Satoshi Tanno; Takeshi Obara; Kazuya Koizumi; Yasuhiro Nakano; Manabu Osanai; Yusuke Mizukami; Yutaka Kohgo
Journal:  Clin J Gastroenterol       Date:  2009-10-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.